COMPUGEN LTD (CGEN)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2027-03-01 | Phase2 Readout | — |
Active Clinical Trials (2)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06888921 | A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer | PHASE2 | Recruiting | 60 |
| NCT06759649 | A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies | PHASE1 | Recruiting | 200 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.